Post job

Casi Pharmaceuticals CEO and executives

Executive Summary. Based on our data team's research, Wei-Wu He Ph.d. is the Casi Pharmaceuticals's CEO. Casi Pharmaceuticals has 118 employees, of which 19 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Casi Pharmaceuticals executive team is 47% female and 53% male.
  • 22% of the management team is White.
  • 3% of Casi Pharmaceuticals management is Hispanic or Latino.
  • 3% of the management team is Black or African American.
Work at Casi Pharmaceuticals?
Share your experience

Rate Casi Pharmaceuticals' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Wei-Wu He Ph.d.

Chairman & Chief Executive Officer

Wei-Wu He Ph.d.'s LinkedIn

John Holaday

Founder

Rajesh C. Shrotriya

MD

Quan Zhou

Board Member

Alexander A. Zukiwski

Chief Medical Officer

Alexander A. Zukiwski's LinkedIn

Alexander A. Zukiwski is a CMO at CASI PHARMACEUTICALS, INC. and is based in United States.

Franklin Cary Salisbury

Board Member

James Z. Huang

Board Member

Cissy Wang

Chief Operating Officer

Cissy Wang's LinkedIn

Cissy wang is a COO at CASI PHARMACEUTICALS, INC. and is based in China. She has worked as MA & HRD at Schneider Electric, HRD & VP at Tyco Healthcare and GSA, and VP at Vcanbio Cell & Gene Engineering Corp Ltd. Cissy studied at University of Chinese Academy of Sciences between 2014 and 2018, Northeastern University between 1990 and 1994, and DongBei University between 1990 and 1994.

Cynthia W. Hu

Chief Operating Officer(US), General Counsel and Secretary

Cynthia W. Hu's LinkedIn

Responsible for all aspects of public company operations; public and private fundraising; mergers & acquisitions; biotechnology; pharmaceuticals; investor relations; strategy and execution; legal and regulatory compliance; executive compensation; board and corporate governance; finance operations; human resources; shareholders relations

James E. Goldschmidt

Chief Business Development Officer

Do you work at Casi Pharmaceuticals?

Does leadership effectively guide Casi Pharmaceuticals toward its goals?

Casi Pharmaceuticals jobs

Casi Pharmaceuticals founders

Name & TitleBio
John Holaday

Founder

Casi Pharmaceuticals board members

Name & TitleBio
Wei-Wu He Ph.d.

Chairman & Chief Executive Officer

Wei-Wu He Ph.d.'s LinkedIn

Rajesh C. Shrotriya

MD

Quan Zhou

Board Member

Franklin Cary Salisbury

Board Member

James Z. Huang

Board Member

Y. Alexander Wu

Board Member

Junping Chen

Board Member

Michael Wu

Board Member

Yue Wu

Board Member

Zuie Chin Huang

Board Member

Casi Pharmaceuticals leadership demographics

Casi Pharmaceuticals gender distribution in management team

  • The Casi Pharmaceuticals executive team is 47% female and 53% male.
  • Casi Pharmaceuticals is 56% female and 44% male company-wide.
Male
Male
53%
Company-wide: 44%
Female
Female
47%
Company-wide: 56%

Casi Pharmaceuticals executives by race

Management Team:
  • The most common ethnicity among Casi Pharmaceuticals executive officers is Asian.
  • 71% of the management team is Asian.
  • 22% of Casi Pharmaceuticals's management is White.
  • 3% of the management team is Black or African American.
Company-wide:
  • White is the most common ethnicity company-wide.
  • 54% of employees are White.
  • 19% of employees are Black or African American.
  • 12% of employees are Hispanic or Latino.
  • Management team
  • General
100%
80%
60%
40%
20%
0%
Unknown
White
Black or African American
Asian
Hispanic or Latino

Casi Pharmaceuticals jobs nearby

Casi Pharmaceuticals executives FAQs

Zippia gives an in-depth look into the details of Casi Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Casi Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Casi Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Casi Pharmaceuticals. The data presented on this page does not represent the view of Casi Pharmaceuticals and its employees or that of Zippia.

Casi Pharmaceuticals may also be known as or be related to CASI PHARMACEUTICALS INC., CASI Pharmaceuticals, CASI Pharmaceuticals Inc, CASI Pharmaceuticals, Inc., Casi Pharmaceuticals and EntreMed Inc.